| 标题 |
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 作者:Gadgeel SM; Rodríguez-Abreu D; Halmos B; Garassino MC; Kurata T; et al 出版日期:2024/08/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)